Sign in
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2019
Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved DME
Carl W. Baker, MD, FASRS
ASRS Updates in the Management of Diabetic Retinopathy DME and PDR in the Middle East and Africa
Sunir J. Garg, MD, FACS, FASRS
Webinars and Journal Clubs
2023
Category: Diabetic Retinopathy